NCT03623555

Brief Summary

Intimate partner violence (IPV) is the most common and alarming form of violence against women, affecting up to 25% of all women in Catalonia. It is a complex phenomenon that involves aspects of social interaction, cognitive-emotional processes, neurobiological alterations and cultural context. Using an integrative methodology, IPV will be approached as a form of chronic exposure to severe stress that alters the stress-response system of exposed women, affecting their capacity to cope with future everyday situations. Fortunately, coping strategies can be subject to change through learning mechanisms and thus the identification of vulnerabilities can help build resilience strategies that may have a long-lasting impression on women's healthy functioning. It is proposed that the sustained exposure to violent social interactions impacts two key aspects of future behavior: i) altered psychosocial coping, and ii) enhanced emotional reactivity to acute stress. To test this hypothesis, the psychosocial and neurobiological response to common social acute stress will be analyzed among women with and without previous exposure to IPV. The Trier Social Stress Task (TSST) will be used, which is a valid test of acute stress that resembles the real life situation of a (mock) job interview. Based on a social neuroscience perspective, quantitative and qualitative measures will be used of cognitive performance, neuroendocrine activity and face-to-face interviews to obtain an integrative description of the response to the TSST that includes the personal narrative of the experience by women themselves. Finally, the proposal will benefit from the fact that all participants will share the same experimental condition (the TSST), and this mock job interview will be used as the common reference point for a workshop about the difficulties and strengths put to test during a stressful situation. The focus of this workshop will be on raising awareness of such coping limitations and abilities that participants themselves will be able to identify. The results of this workshop will inform guidelines and recommendations for future work and prevention strategies, and participants will be invited to be an active part in our dissemination strategy

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
172

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 23, 2018

Completed
17 days until next milestone

First Posted

Study publicly available on registry

August 9, 2018

Completed
7 months until next milestone

Study Start

First participant enrolled

March 1, 2019

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2020

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2020

Completed
Last Updated

May 6, 2019

Status Verified

May 1, 2019

Enrollment Period

10 months

First QC Date

July 23, 2018

Last Update Submit

May 3, 2019

Conditions

Keywords

Stress regulationDepressionIntimate partner violenceResiliencePsychophysiologyEndocrine responseRisk factor

Outcome Measures

Primary Outcomes (1)

  • Salivary cortisol

    Salivary cortisol concentration levels

    Recovery after acute stress response experiment (TSST): 45 minutes

Secondary Outcomes (1)

  • Behavioral response

    Recovery after acute stress response experiment (TSST): 45 minutes

Study Arms (2)

E-IPV

Women who have been exposed to intimate partner violence. Half of this group will also have a history of childhood maltreatment. Women will be assessed for behavioral performance during the Trier Social Stress Test, and salivary cortisol will be collected.

Behavioral: Trier Social Stress TestBiological: Salivary cortisol

NE-IPV

Women who have never been exposed to intimate partner violence. Half of this group will also present a diagnosis of Major Depressive Disorder. Women will be assessed for behavioral performance during the Trier Social Stress Test, and salivary cortisol will be collected.

Behavioral: Trier Social Stress TestBiological: Salivary cortisol

Interventions

The participants are instructed to imagine having applied for their "dream job" and that they are now invited to a job interview. The TSST consists of three successive phases: (1) A preparation period (3min), (2) a free speech task in which the participants have to argue why they are the best candidate for the job they wish to apply for (5min), and (3) a mental arithmetic task in which participants have to sequentially subtract an odd two-digit number from an odd four-digit number (e.g., 17 from 2023; 5min). The two tasks are performed in front of a selection committee (two members), dressed in white lab coats, acting in a reserved manner and providing no facial or verbal feedback.

E-IPVNE-IPV

Saliva samples will be obtained by means of Salivette collection devices before, 10 minutes after, and 30 minutes after the beginning of the TSST

E-IPVNE-IPV

Eligibility Criteria

Age25 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

The population under study are women between 25 and 45 years of age

You may qualify if:

  • E-IPV group: - past history of at least 1 year of IPV exposure after the age of 18.
  • At least one year of established cessation of exposure to IPV
  • Subgroup with childhood maltreatment: - history of childhood maltreatment before the age of 16.
  • NE-IPV group: - no history of IPV lifetime
  • no history of childhood maltreatment
  • Subgroup with major depression disorder: - Presence of major depression disorder in the last year

You may not qualify if:

  • Age under 25 or over 45 years old.
  • Endocrine alteration, including steroid-based illness/medication
  • Pregnancy (last 6 months), current breast-feeding.
  • Current disability or illness that may cause inability to read or comprehend instructions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Parc Taulí University Hospital

Sabadell, Barcelona, Spain

RECRUITING

Related Publications (9)

  • Li SH, Graham BM. Why are women so vulnerable to anxiety, trauma-related and stress-related disorders? The potential role of sex hormones. Lancet Psychiatry. 2017 Jan;4(1):73-82. doi: 10.1016/S2215-0366(16)30358-3. Epub 2016 Nov 15.

    PMID: 27856395BACKGROUND
  • Kuehner C. Why is depression more common among women than among men? Lancet Psychiatry. 2017 Feb;4(2):146-158. doi: 10.1016/S2215-0366(16)30263-2. Epub 2016 Nov 15.

    PMID: 27856392BACKGROUND
  • Inslicht SS, Marmar CR, Neylan TC, Metzler TJ, Hart SL, Otte C, McCaslin SE, Larkin GL, Hyman KB, Baum A. Increased cortisol in women with intimate partner violence-related posttraumatic stress disorder. Psychoneuroendocrinology. 2006 Aug;31(7):825-38. doi: 10.1016/j.psyneuen.2006.03.007. Epub 2006 May 23.

    PMID: 16716530BACKGROUND
  • Pinna KL, Johnson DM, Delahanty DL. PTSD, comorbid depression, and the cortisol waking response in victims of intimate partner violence: preliminary evidence. Anxiety Stress Coping. 2014 May;27(3):253-69. doi: 10.1080/10615806.2013.852185. Epub 2013 Nov 28.

    PMID: 24283327BACKGROUND
  • Belda X, Fuentes S, Daviu N, Nadal R, Armario A. Stress-induced sensitization: the hypothalamic-pituitary-adrenal axis and beyond. Stress. 2015;18(3):269-79. doi: 10.3109/10253890.2015.1067678. Epub 2015 Aug 17.

    PMID: 26300109BACKGROUND
  • Oram S, Khalifeh H, Howard LM. Violence against women and mental health. Lancet Psychiatry. 2017 Feb;4(2):159-170. doi: 10.1016/S2215-0366(16)30261-9. Epub 2016 Nov 15.

    PMID: 27856393BACKGROUND
  • Kirschbaum C, Pirke KM, Hellhammer DH. The 'Trier Social Stress Test'--a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology. 1993;28(1-2):76-81. doi: 10.1159/000119004.

    PMID: 8255414BACKGROUND
  • Frisch JU, Hausser JA, Mojzisch A. The Trier Social Stress Test as a paradigm to study how people respond to threat in social interactions. Front Psychol. 2015 Feb 2;6:14. doi: 10.3389/fpsyg.2015.00014. eCollection 2015.

    PMID: 25698987BACKGROUND
  • Goldberg X, Espelt C, Palao D, Nadal R, Armario A. Adaptability to acute stress among women survivors of intimate partner violence: protocol for a mixed-methods cross-sectional study in a laboratory setting (BRAW study). BMJ Open. 2020 Oct 1;10(10):e036561. doi: 10.1136/bmjopen-2019-036561.

Related Links

Biospecimen

Retention: SAMPLES WITH DNA

Whole blood, saliva, hair

MeSH Terms

Conditions

Depressive DisorderDepression

Interventions

Psychological Tests

Condition Hierarchy (Ancestors)

Mood DisordersMental DisordersBehavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Behavioral Disciplines and Activities

Central Study Contacts

Ximena Goldberg, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 23, 2018

First Posted

August 9, 2018

Study Start

March 1, 2019

Primary Completion

January 1, 2020

Study Completion

September 1, 2020

Last Updated

May 6, 2019

Record last verified: 2019-05

Locations